AIM
ACOR
Alambic Investment Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-15,543
| Closed | -$446K | – | 391 |
|
|
2018
Q2 | $446K | Sell |
15,543
-156,900
| -91% | -$4.5M | 0.12% | 226 |
|
|
2018
Q1 | $4.08M | Sell |
172,443
-23,300
| -12% | -$551K | 0.57% | 37 |
|
|
2017
Q4 | $4.2M | Sell |
195,743
-41,800
| -18% | -$897K | 0.51% | 53 |
|
|
2017
Q3 | $5.62M | Buy |
237,543
+19,933
| +9% | +$471K | 0.61% | 30 |
|
|
2017
Q2 | $4.29M | Buy |
217,610
+91,011
| +72% | +$1.79M | 0.52% | 39 |
|
|
2017
Q1 | $2.66M | Buy |
126,599
+35,400
| +39% | +$744K | 0.33% | 77 |
|
|
2016
Q4 | $1.72M | Buy |
91,199
+48,786
| +115% | +$917K | 0.3% | 104 |
|
|
2016
Q3 | $886K | Buy |
42,413
+21,750
| +105% | +$454K | 0.21% | 180 |
|
|
2016
Q2 | $527K | Buy |
20,663
+900
| +5% | +$23K | 0.13% | 267 |
|
|
2016
Q1 | $523K | Buy |
+19,763
| New | +$523K | 0.17% | 207 |
|